Outcome of a Questionnaire within European Pharmaceutical Aerosol Group (EPAG) Companies Concerning the Implementation of the Abbreviated Impactor Measurement (AIM) Concept for the Assessment of Orally Inhaled Product (OIP) Aerosol Aerodynamic Particle Size Properties

Contact

European Pharmaceutical
Aerosol Group

EPAG
European Pharmaceutical Aerosol Group
PO Box 3486
BRISTOL, BS4 9HU
United Kingdom